BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29463311)

  • 21. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.
    Zhang X; Lv D; Zhang Y; Liu Q; Li Z
    Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
    Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
    Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
    López-Corral L; Gutiérrez NC; Vidriales MB; Mateos MV; Rasillo A; García-Sanz R; Paiva B; San Miguel JF
    Clin Cancer Res; 2011 Apr; 17(7):1692-700. PubMed ID: 21325290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple Myeloma: Molecular Pathogenesis and Disease Evolution.
    Heider M; Nickel K; Högner M; Bassermann F
    Oncol Res Treat; 2021; 44(12):672-681. PubMed ID: 34749378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional significance of genetic abnormalities in multiple myeloma.
    Gadó K; Domján G; Kormos L; Falus A
    Haematologia (Budap); 2002; 32(3):191-208. PubMed ID: 12611480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow.
    Hansmann L; Han A; Penter L; Liedtke M; Davis MM
    Cancer Immunol Res; 2017 Sep; 5(9):744-754. PubMed ID: 28768640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic profiling of multiple myeloma: New insights and modern technologies.
    Hultcrantz M; Yellapantula V; Rustad EH
    Best Pract Res Clin Haematol; 2020 Mar; 33(1):101153. PubMed ID: 32139018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined morphological and interphase fluorescence in situ hybridization study in multiple myeloma of Chinese patients.
    Ng MH; Kan A; Chung YF; Wong IH; Lo KW; Wickham NW; Lei KI; Lee JC
    Am J Pathol; 1999 Jan; 154(1):15-22. PubMed ID: 9916913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular Mechanism and Malignant Clonal Evolution of Multiple Myeloma].
    Ding F; Zhu P; Wu XQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1513-6. PubMed ID: 26524068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilizing next-generation sequencing in the management of multiple myeloma.
    Lionetti M; Neri A
    Expert Rev Mol Diagn; 2017 Jul; 17(7):653-663. PubMed ID: 28524737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Darwinian evolution and tiding clones in multiple myeloma.
    Bahlis NJ
    Blood; 2012 Aug; 120(5):927-8. PubMed ID: 22859708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of central nervous system myelomatosis with complex chromosome aberrations].
    Bang HI; Yoo JY; Kim KH; Park R; Shin JW; Choi TY; Lee SC; Park HS; Won JH
    Korean J Lab Med; 2010 Aug; 30(4):334-8. PubMed ID: 20805703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Myeloma Genomics - A Concise Review.
    Castaneda O; Baz R
    Acta Med Acad; 2019 Apr; 48(1):57-67. PubMed ID: 31264433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal evolution of one rare case of multiple myeloma with bilateral testicular mass as initial presentation.
    Lin N; Wu Y; Liang Y; Mo W; Li Y; Zhang R
    Ann Hematol; 2020 Feb; 99(2):377-378. PubMed ID: 31879789
    [No Abstract]   [Full Text] [Related]  

  • 35. Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma.
    Hajek R; Okubote SA; Svachova H
    Br J Haematol; 2013 Dec; 163(5):551-64. PubMed ID: 24111932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the BRAF V600E mutation in multiple myeloma.
    Andrulis M; Lehners N; Capper D; Penzel R; Heining C; Huellein J; Zenz T; von Deimling A; Schirmacher P; Ho AD; Goldschmidt H; Neben K; Raab MS
    Cancer Discov; 2013 Aug; 3(8):862-9. PubMed ID: 23612012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The pathology and genetic background of myeloma].
    Timár B
    Magy Onkol; 2016 Jun; 60(2):145-53. PubMed ID: 27275641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance.
    Kim SY; Im K; Park SN; Kim JA; Yoon SS; Lee DS
    Leuk Res; 2016 May; 44():45-52. PubMed ID: 27015231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular aspects of multiple myeloma.
    Kastrinakis NG; Gorgoulis VG; Foukas PG; Dimopoulos MA; Kittas C
    Ann Oncol; 2000 Oct; 11(10):1217-28. PubMed ID: 11106109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation.
    Chitre S; Stölzel F; Cuthill K; Streetly M; Graham C; Dill C; Mohamedali A; Smith A; Schetelig J; Altmann H; Bornhäuser M; Mufti GJ
    Leukemia; 2018 Sep; 32(9):2020-2024. PubMed ID: 30026569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.